Yuanta Securities analyzed on November 21 that InBody is expected to see growth in its previously stagnant domestic sales. The firm did not provide an investment opinion or target price.

[Click eStock] "InBody Expected to See Domestic Sales Growth" View original image

The customized health functional food system, a service that divides and combines more than one health supplement according to each consumer’s health status and needs, has been in effect since February this year. Consultations with specialists such as pharmacists and nutritionists are required in advance. As a result, there is growing demand to utilize body composition data to better understand customers’ conditions.


Kwon Myungjun, a researcher at Yuanta Securities, stated, “As of November this year, around 70 pharmacies have already adopted and are using InBody devices. We believe there is high potential for expansion, as InBody can contribute to improving the profitability of pharmacies, which is a factor expected to drive sales growth in the previously stagnant domestic market.”


Collaboration with Naver is also an area of anticipation. On October 29, Naver acquired 1,145,875 treasury shares of the company (an 8.5% stake) to strengthen its global healthcare business cooperation. Researcher Kwon Myungjun commented, “InBody possesses body composition data and has also established a global network. Naver is currently pursuing global expansion of its healthcare business, so their interests are well aligned.”



In the third quarter of this year, revenue reached 59.8 billion won and operating profit was 9.8 billion won, up 17.9% and 0.1%, respectively, compared to the same period last year. He explained, “Quarterly revenue hit a record high, marking the seventh consecutive quarter of record-breaking sales. While domestic sales declined year-on-year, overseas sales continued to grow.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing